In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed
ID: NIH_NIDA75N95025XXXXType: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Diagnostic Imaging Centers (621512)

PSC

IMAGING EQUIPMENT AND SUPPLIES: MEDICAL, DENTAL, VETERINARY (6525)

Original Source

https://sam.gov/opp/e3d7b60a1b964476879f69afe1d95793/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking innovative proposals for the development of In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems. The initiative aims to address the challenges posed by light scattering in biological tissues, which currently limits the effectiveness of non-invasive optical imaging techniques in assessing tissue function and structure. This funding opportunity encourages the advancement of next-generation imaging technologies that can achieve deeper penetration and higher resolution in biological systems. Interested applicants should note that the application due date is March 7, 2025, by 5:00 PM local time, and are encouraged to submit a letter of intent by the same date. For further inquiries, contact Jonathan Pollock at jpollock@mail.nih.gov or Robert Bailey at rob.bailey@nih.gov.

    Point(s) of Contact
    Jonathan Pollock
    (301) 435-1309
    jpollock@mail.nih.gov
    Robert Bailey
    (301) 451-7586
    rob.bailey@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    ARPA-H ImagiNg Data EXchange (INDEX)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Imaging Data Exchange (INDEX) program aimed at enhancing access to medical imaging data. The primary objective is to develop a sustainable platform that connects medical imaging data providers with researchers and developers, leveraging artificial intelligence and machine learning to address the shortage of qualified radiologists and improve healthcare outcomes. This initiative is critical for advancing algorithm development and clinical studies by creating a comprehensive repository of diverse imaging datasets, including cancer digital pathology and surgical videos. Interested parties must submit their Solution Summary by January 28, 2025, with the full proposal due by March 27, 2025. For further inquiries, contact the INDEX Team at INDEX@arpa-h.gov.
    Development of Radiation/Nuclear Medical Countermeasures (MCMs) And Biodosimetry Devices
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the development of Radiation/Nuclear Medical Countermeasures (MCMs) and biodosimetry devices. The primary objectives are to create effective MCMs that mitigate normal tissue injuries from ionizing radiation and to advance biodosimetry tools that enhance triage and treatment strategies during radiation emergencies. This initiative is crucial for national preparedness against potential radiological incidents, as it aims to address the urgent need for medical interventions and diagnostic capabilities in mass casualty scenarios. Proposals are due by March 19, 2025, with an estimated funding of $2 million annually for successful applicants over a typical three-year contract period, totaling a possible award of $6 million. For further inquiries, interested parties may contact Albert Nguyen at nguyenal@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov.
    Ocular Laboratory for Analysis of Biomarkers (OCULAB)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is announcing a Proposers' Day for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) program. This initiative aims to develop non-invasive diagnostic technologies for ocular and systemic conditions, particularly focusing on dry eye disease, through two primary technical areas: sensor technology for continuous biomarker monitoring and closed-loop therapeutic dosing systems. The Proposers' Day, scheduled for December 12, 2024, in Tampa Bay, Florida, will facilitate collaboration among participants and provide insights into the program's goals, with registration open from October 18, 2024, to December 5, 2024. Interested parties can contact OCULAB@ARPA-H.gov for further information and are encouraged to register for the event to enhance their proposal submissions.
    Emerging Health Innovators (EHI) Initiative
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Emerging Health Innovators (EHI) Initiative, aimed at fostering innovative biomedical solutions from early-career researchers and community-based organizations. This initiative invites submissions under two tracks: Technology-Driven Innovation and Community-Centered Innovation, with a focus on addressing significant gaps in health innovation and community health management. Proposals may seek funding up to $350,000 annually for a duration of two years, with a potential extension for a third year, and must adhere to strict compliance guidelines regarding research security, intellectual property, and human and animal subject research. Interested parties should contact the EHI Initiative Team at EHI@ARPA-H.gov, with proposals due by February 5, 2025, following a Proposers' Day on January 8, 2025.
    Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
    National Institute of Environmental Health Sciences (NIEHS) Assessment of Immunotoxicity – In Vitro and In Vivo Assessment of Immune Function
    Health And Human Services, Department Of
    The National Institute of Environmental Health Sciences (NIEHS), part of the Department of Health and Human Services, is seeking proposals for a contract focused on the assessment of immunotoxicity through both in vitro and in vivo studies of immune function. The primary objective is to evaluate how selected chemical agents modify immune responses, utilizing established testing models to enhance understanding of immunotoxicity while aiming to reduce animal use in research. This initiative is critical for advancing toxicological assessments and ensuring compliance with federal standards in environmental health research. Interested contractors must submit their proposals by 4:00 PM EST on February 18, 2025, and can direct inquiries to Adam Muhsin at adam.muhsin@nih.gov or Erica Kitzmiller at erica.kitzmiller@nih.gov.
    Toxicity testing on a new PET ligand (Sources Sought)
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified contractors to conduct a toxicity study on a new PET ligand, Fluorine-18-Fluorocellobiose, as part of the Investigational New Drug (IND) application process. The project entails performing a single-dose toxicity study on Sprague Dawley rats, adhering to FDA's Good Laboratory Practice (GLP) standards, with the aim of assessing toxicity endpoints and developing analytical methods for drug level evaluation. This initiative underscores NIH's commitment to advancing biomedical research while ensuring compliance with regulatory requirements in drug development. Interested parties must submit their responses, including company information and capability statements, to Grace Wong-Darko at Grace.Wong-Darko@nih.gov by 1:00 PM EST on January 31, 2025.
    ARPA-H ImagiNg Data EXchange (INDEX)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is announcing the ImagiNg Data EXchange (INDEX) program, aimed at enhancing access to medical imaging data for the development of artificial intelligence (AI) and machine learning (ML) algorithms in healthcare. The program seeks to establish a sustainable platform that connects data providers and users, focusing on business model development in its initial phase and system architecture in the subsequent phase. This initiative is crucial for facilitating cancer-related research and improving surgical procedures by ensuring efficient access to diverse medical imaging datasets. Interested proposers are encouraged to participate in a Proposers' Day on January 9, 2025, in Seattle, Washington, where they can learn more about the program and register for participation. For further inquiries, potential proposers can contact the INDEX Team at INDEX@arpa-h.gov.
    Fiber Photometry Processors
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information from small businesses regarding their capabilities to provide Fiber Photometry Processors, particularly the RZ5P model, which is essential for data acquisition and processing in the study of substance use disorders. The processors will be used to record neurotransmitter activity, such as dopamine, during behavioral experiments and substance administration, contributing to the understanding of substance use disorder mechanisms. Interested small businesses, including those classified as HUBZone, service-disabled veteran-owned, and woman-owned, are invited to submit a capability statement detailing their qualifications and relevant experience by January 29, 2025. For further inquiries, potential respondents can contact Joseph Kennedy at joseph.kennedy@nih.gov or Marlene Milgram at marlene.milgram@nih.gov.
    Ocular Laboratory for Analysis of Biomarkers (OCULAB)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) initiative. This program aims to develop innovative biosensor technologies for the continuous monitoring of tear biomarkers and AI-driven therapeutic delivery systems, particularly targeting conditions such as dry eye disease (DED). The initiative emphasizes collaboration among commercial entities and academic institutions to enhance diagnostic and treatment capabilities, ultimately striving to improve patient outcomes and healthcare accessibility. Interested parties should contact the OCULAB Team at OCULAB@ARPA-H.gov for further details, with multiple awards anticipated as part of this funding opportunity.